HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today its financial results for the first quarter of 2007. Nymox reported a net loss of $1,132,520, or $0.04 per share for the quarter ending March 31, 2007, compared to $1,059,246, or $0.04 per share for same period in 2006. The increase in the net loss is attributable to stock-based compensation costs of $242,695 compared to $4,055 for the same period in 2006. Product sales amounted to $136,404 for the first quarter of 2007, compared to $95,259 for the same period in 2006. The weighted, diluted average number of common shares at March 31, 2007 was 29,141,752, compared to 26,999,213 at March 31, 2006.
